Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney Injury

Acute kidney injury (AKI) has impacted a heavy burden on global healthcare system with a high morbidity and mortality in both hospitalized and critically ill patients. However, there are still some shortcomings in clinical approaches for the disease to date, appealing for an earlier recognition and...

Full description

Bibliographic Details
Main Authors: Yiwen Ying, Qian Tang, Da Han, Shan Mou
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/6/3093
_version_ 1797470888633827328
author Yiwen Ying
Qian Tang
Da Han
Shan Mou
author_facet Yiwen Ying
Qian Tang
Da Han
Shan Mou
author_sort Yiwen Ying
collection DOAJ
description Acute kidney injury (AKI) has impacted a heavy burden on global healthcare system with a high morbidity and mortality in both hospitalized and critically ill patients. However, there are still some shortcomings in clinical approaches for the disease to date, appealing for an earlier recognition and specific intervention to improve long-term outcomes. In the past decades, owing to the predictable base-pairing rule and highly modifiable characteristics, nucleic acids have already become significant biomaterials for nanostructure and nanodevice fabrication, which is known as nucleic acid nanotechnology. In particular, its excellent programmability and biocompatibility have further promoted its intersection with medical challenges. Lately, there have been an influx of research connecting nucleic acid nanotechnology with the clinical needs for renal diseases, especially AKI. In this review, we begin with the diagnostics of AKI based on nucleic acid nanotechnology with a highlight on aptamer- and probe-functionalized detection. Then, recently developed nanoscale nucleic acid therapeutics towards AKI will be fully elucidated. Furthermore, the strengths and limitations will be summarized, envisioning a wiser and wider application of nucleic acid nanotechnology in the future of AKI.
first_indexed 2024-03-09T19:42:18Z
format Article
id doaj.art-4c39ef060d0f42f6b243101c4e3d1650
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T19:42:18Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-4c39ef060d0f42f6b243101c4e3d16502023-11-24T01:32:14ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-03-01236309310.3390/ijms23063093Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney InjuryYiwen Ying0Qian Tang1Da Han2Shan Mou3Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaInstitute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaInstitute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaDepartment of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaAcute kidney injury (AKI) has impacted a heavy burden on global healthcare system with a high morbidity and mortality in both hospitalized and critically ill patients. However, there are still some shortcomings in clinical approaches for the disease to date, appealing for an earlier recognition and specific intervention to improve long-term outcomes. In the past decades, owing to the predictable base-pairing rule and highly modifiable characteristics, nucleic acids have already become significant biomaterials for nanostructure and nanodevice fabrication, which is known as nucleic acid nanotechnology. In particular, its excellent programmability and biocompatibility have further promoted its intersection with medical challenges. Lately, there have been an influx of research connecting nucleic acid nanotechnology with the clinical needs for renal diseases, especially AKI. In this review, we begin with the diagnostics of AKI based on nucleic acid nanotechnology with a highlight on aptamer- and probe-functionalized detection. Then, recently developed nanoscale nucleic acid therapeutics towards AKI will be fully elucidated. Furthermore, the strengths and limitations will be summarized, envisioning a wiser and wider application of nucleic acid nanotechnology in the future of AKI.https://www.mdpi.com/1422-0067/23/6/3093nucleic acid nanotechnologyAKIaptamerframework nucleic acidsdiagnosistargeted therapy
spellingShingle Yiwen Ying
Qian Tang
Da Han
Shan Mou
Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney Injury
International Journal of Molecular Sciences
nucleic acid nanotechnology
AKI
aptamer
framework nucleic acids
diagnosis
targeted therapy
title Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney Injury
title_full Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney Injury
title_fullStr Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney Injury
title_full_unstemmed Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney Injury
title_short Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney Injury
title_sort nucleic acid nanotechnology for diagnostics and therapeutics in acute kidney injury
topic nucleic acid nanotechnology
AKI
aptamer
framework nucleic acids
diagnosis
targeted therapy
url https://www.mdpi.com/1422-0067/23/6/3093
work_keys_str_mv AT yiwenying nucleicacidnanotechnologyfordiagnosticsandtherapeuticsinacutekidneyinjury
AT qiantang nucleicacidnanotechnologyfordiagnosticsandtherapeuticsinacutekidneyinjury
AT dahan nucleicacidnanotechnologyfordiagnosticsandtherapeuticsinacutekidneyinjury
AT shanmou nucleicacidnanotechnologyfordiagnosticsandtherapeuticsinacutekidneyinjury